Cargando…
Rho Kinase in Eye Disease
Autores principales: | Okumura, Naoki, Nakao, Shintaro, Inoue, Toshihiro, Pattabiraman, Padmanabhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591981/ https://www.ncbi.nlm.nih.gov/pubmed/28928984 http://dx.doi.org/10.1155/2017/9281745 |
Ejemplares similares
-
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
por: Okumura, Naoki, et al.
Publicado: (2017) -
Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases
por: Yamaguchi, Muneo, et al.
Publicado: (2017) -
Targeting Rho Associated Kinases in Leukemia and Myeloproliferative Neoplasms
por: Mali, Raghuveer Singh, et al.
Publicado: (2012) -
Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study
por: Nakagawa, Hiroko, et al.
Publicado: (2015) -
Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage
por: Arita, Ryoichi, et al.
Publicado: (2009)